Get a demo
Log In
EDGE Insights

EDGE Insights

This week:
Last week:
AI Drug Discovery

AI Drug Discovery

The LEGO of life: Building new organisms with generative biology

Imagine you want to build the Golden Gate Bridge with LEGO bricks. You could use what you have on hand—generic bricks and bricks from other LEGO sets. No matter how well you fit the pieces together, your final product will never be exactly what you envisioned. But what if LEGO designed a special LEGO set of the Golden Gate Bridge?* You could be sure that the finished product would look exactly as you pictured it.
What if the same concept could be applied to drug discovery? What if therapeutic molecules could be designed from scratch to perfectly match their target? Enter generative biology, which aims to do just that.
This Insight delves into how generative biology relates to AI drug discovery, discussing the factors driving and challenging its adoption, and identifying the companies in the space.
Completing a set gives LEGO builders a sense of pride and satisfaction. How infinitely more gratifying it would be to “build” a protein with the desired structures and properties that allow it to meet a specific therapeutic need and bring relief to more patientseven those with the rarest diseasesmore quickly.
* At the time of writing, LEGO had the 21043 San Francisco set, which includes the Golden Gate Bridge in a small version, but not as a separate, larger set.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.